During the past decade, Praxis Fuer Haematologie Internistische Onkologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Praxis Fuer Haematologie Internistische Onkologie" #1 sponsor was "German CLL Study Group" with 4 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials sponsored, "Heinrich-Heine University, Duesseldorf" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "III. Medizinische Klinik Mannheim" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Praxis Fuer Haematologie Internistische Onkologie" #1 collaborator was "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Praxis Fuer Haematologie Internistische Onkologie" are "Chronic Lymphocytic Leukemia" (4 trials), "Lymphoma" (4 trials), "Leukemia" (2 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Praxis Fuer Haematologie Internistische Onkologie" in a lesser frequency.

Most popular intervention types in "Praxis Fuer Haematologie Internistische Onkologie" are "Drug" (11 trials), "Biological" (7 trials), "Radiation" (4 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (6 trials), "doxorubicin hydrochloride" (5 trials), "prednisone" (4 trials), "radiation therapy" (4 trials) and "rituximab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Praxis Fuer Haematologie Internistische Onkologie" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Praxis Fuer Haematologie Internistische Onkologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Praxis Fuer Haematologie Internistische Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Praxis Fuer Haematologie Internistische Onkologie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".